Carina Diehl, Valeria Soberón, Seren Baygün, Yuanyan Chu, Jonathan Mandelbaum, Laura Kraus, Thomas Engleitner, Martina Rudelius, Marco Fangazio, Christoph Daniel, Sabrina Bortoluzzi, Sabine Helmrath, Pankaj Singroul, Vanessa Gölling, Francisco Osorio Barrios, Gönül Seyhan, Lena Oßwald, Maike Kober-Hasslacher, Theodor Zeng, Rupert Öllinger, Marc Schmidt-Supprian
{"title":"Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis","authors":"Carina Diehl, Valeria Soberón, Seren Baygün, Yuanyan Chu, Jonathan Mandelbaum, Laura Kraus, Thomas Engleitner, Martina Rudelius, Marco Fangazio, Christoph Daniel, Sabrina Bortoluzzi, Sabine Helmrath, Pankaj Singroul, Vanessa Gölling, Francisco Osorio Barrios, Gönül Seyhan, Lena Oßwald, Maike Kober-Hasslacher, Theodor Zeng, Rupert Öllinger, Marc Schmidt-Supprian","doi":"10.1016/j.immuni.2024.11.023","DOIUrl":null,"url":null,"abstract":"B cell immunity carries the inherent risk of deviating into autoimmunity and malignancy, which are both strongly associated with genetic variants or alterations that increase immune signaling. Here, we investigated the interplay of autoimmunity and lymphoma risk factors centered around the archetypal negative immune regulator <em>TNFAIP3</em>/A20 in mice. Counterintuitively, B cells with moderately elevated sensitivity to stimulation caused fatal autoimmune pathology, while those with high sensitivity did not. We resolved this apparent paradox by identifying a rheostat-like cytotoxic T cell checkpoint. Cytotoxicity was instructed by and directed against B cells with high intrinsic hyperresponsiveness, while less reactive cells were spared. Removing T cell control restored a linear relationship between intrinsic B cell reactivity and lethal lymphoproliferation, lymphomagenesis, and autoinflammation. We thus identify powerful T cell-mediated negative feedback control of inherited and acquired B cell pathogenicity and define a permissive window for autoimmunity to emerge.","PeriodicalId":13269,"journal":{"name":"Immunity","volume":"62 1","pages":""},"PeriodicalIF":25.5000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.immuni.2024.11.023","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
B cell immunity carries the inherent risk of deviating into autoimmunity and malignancy, which are both strongly associated with genetic variants or alterations that increase immune signaling. Here, we investigated the interplay of autoimmunity and lymphoma risk factors centered around the archetypal negative immune regulator TNFAIP3/A20 in mice. Counterintuitively, B cells with moderately elevated sensitivity to stimulation caused fatal autoimmune pathology, while those with high sensitivity did not. We resolved this apparent paradox by identifying a rheostat-like cytotoxic T cell checkpoint. Cytotoxicity was instructed by and directed against B cells with high intrinsic hyperresponsiveness, while less reactive cells were spared. Removing T cell control restored a linear relationship between intrinsic B cell reactivity and lethal lymphoproliferation, lymphomagenesis, and autoinflammation. We thus identify powerful T cell-mediated negative feedback control of inherited and acquired B cell pathogenicity and define a permissive window for autoimmunity to emerge.
期刊介绍:
Immunity is a publication that focuses on publishing significant advancements in research related to immunology. We encourage the submission of studies that offer groundbreaking immunological discoveries, whether at the molecular, cellular, or whole organism level. Topics of interest encompass a wide range, such as cancer, infectious diseases, neuroimmunology, autoimmune diseases, allergies, mucosal immunity, metabolic diseases, and homeostasis.